Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

David M Kent

Showing results (121-130 of 268) with videos related to

Pageof 27
Sort By:
Journal of General Internal Medicine|July 21, 2010
The empirical basis for determinations of medical futilityEzra Gabbay, Jose Calvo-Broce, Klemens B Meyer, et al.
JAMA|November 15, 2017
Change in Testing, Awareness of Hemoglobin A1c Result, and Glycemic Control in US Adults, 2007-2014Saeid Shahraz, Anastassios G Pittas, Mojdeh Saadati, et al.
Trials|August 14, 2010
Assessing and reporting heterogeneity in treatment effects in clinical trials: a proposalDavid M Kent, Peter M Rothwell, John P A Ioannidis, et al.
Plos One|March 30, 2018
Clinicians' perspectives on incidentally discovered silent brain infarcts - A qualitative studyLester Y Leung, Paul K J Han, Christine Lundquist, et al.
Journal of Clinical Epidemiology|October 16, 2004
Tissue plasminogen activator was cost-effective compared to streptokinase in only selected patients with acute myocardial infarctionDavid M Kent, Sandeep Vijan, Rodney A Hayward, et al.
NPJ Digital Medicine|March 29, 2023
A standardized framework for risk-based assessment of treatment effect heterogeneity in observational healthcare databasesAlexandros Rekkas, David van Klaveren, Patrick B Ryan, et al.
International Journal of Epidemiology|July 5, 2016
Risk and treatment effect heterogeneity: re-analysis of individual participant data from 32 large clinical trialsDavid M Kent, Jason Nelson, Issa J Dahabreh, et al.
Journal of Patient-Reported Outcomes|April 16, 2019
Patients' responses to incidentally discovered silent brain infarcts - a qualitative studyLester Y Leung, Paul K J Han, Christine Lundquist, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|April 11, 2018
Absolute Lymphocyte Count: A Predictor of Recurrent Cytomegalovirus Disease in Solid Organ Transplant RecipientsBradley J Gardiner, Natalie E Nierenberg, Jennifer K Chow, et al.
Plos One|May 17, 2018
Correction: Clinicians' perspectives on incidentally discovered silent brain infarcts - A qualitative studyLester Y Leung, Paul K J Han, Christine Lundquist, et al.
Pageof 27

Showing results (121-130 of 268) with videos related to

Sort By:
Pageof 27
Journal of General Internal Medicine|July 21, 2010
The empirical basis for determinations of medical futilityEzra Gabbay, Jose Calvo-Broce, Klemens B Meyer, et al.
JAMA|November 15, 2017
Change in Testing, Awareness of Hemoglobin A1c Result, and Glycemic Control in US Adults, 2007-2014Saeid Shahraz, Anastassios G Pittas, Mojdeh Saadati, et al.
Trials|August 14, 2010
Assessing and reporting heterogeneity in treatment effects in clinical trials: a proposalDavid M Kent, Peter M Rothwell, John P A Ioannidis, et al.
Plos One|March 30, 2018
Clinicians' perspectives on incidentally discovered silent brain infarcts - A qualitative studyLester Y Leung, Paul K J Han, Christine Lundquist, et al.
Journal of Clinical Epidemiology|October 16, 2004
Tissue plasminogen activator was cost-effective compared to streptokinase in only selected patients with acute myocardial infarctionDavid M Kent, Sandeep Vijan, Rodney A Hayward, et al.
NPJ Digital Medicine|March 29, 2023
A standardized framework for risk-based assessment of treatment effect heterogeneity in observational healthcare databasesAlexandros Rekkas, David van Klaveren, Patrick B Ryan, et al.
International Journal of Epidemiology|July 5, 2016
Risk and treatment effect heterogeneity: re-analysis of individual participant data from 32 large clinical trialsDavid M Kent, Jason Nelson, Issa J Dahabreh, et al.
Journal of Patient-Reported Outcomes|April 16, 2019
Patients' responses to incidentally discovered silent brain infarcts - a qualitative studyLester Y Leung, Paul K J Han, Christine Lundquist, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|April 11, 2018
Absolute Lymphocyte Count: A Predictor of Recurrent Cytomegalovirus Disease in Solid Organ Transplant RecipientsBradley J Gardiner, Natalie E Nierenberg, Jennifer K Chow, et al.
Plos One|May 17, 2018
Correction: Clinicians' perspectives on incidentally discovered silent brain infarcts - A qualitative studyLester Y Leung, Paul K J Han, Christine Lundquist, et al.
Pageof 27